1.2 Contraindications
Your healthcare professional must decide whether insulin pump
therapy is suitable for the treatment of your diabetes mellitus.
Continuous Subcutaneous Insulin Infusion (CSII) with the
micropump system is not recommended or only recommended
with limitations for the following groups of people:
j
People who are not able or willing to perform at least 4 blood
glucose tests per day.
j
People who are not able to be in regular contact with their
healthcare team.
j
People who do not understand what is required for insulin
pump therapy or who are not able to follow the instructions for
use of the micropump system.
j
People who cannot be relied upon due to drug addiction,
substance abuse or mental illness.
j
People who are exposed to high ambient temperatures
(see chapter
Technical Data
).
1.3 Risks and Benefits
Talk to your healthcare team about the benefits and potential
risks that are associated with using the micropump system.
To ensure that insulin pump therapy is safe and successful, you
must actively take part in the therapy, test your blood glucose
values regularly, calculate carbohydrate intake and monitor the
micropump functions regularly.
In case of improper use of the micropump system or non-
compliance with your healthcare professional’s instructions, you
risk experiencing, for example, hypoglycaemia, hyperglycaemia,
ketoacidosis or infections of the infusion site. Follow the
treatment plan you agreed on with your healthcare professional
as well as the setting for basal rate profiles and bolus advice
defined therein.
2
What is the Purpose of the Micropump System?
man_07866364001_A_en.indb 2
28.07.2017 12:15:43